RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM)
Clinical trials for RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM) explained in plain language.
Never miss a new study
Get alerted when new RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM) trials appear
Sign up with your email to follow new studies for RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Two-Pronged cell therapy tested for aggressive blood cancer
Disease control Recruiting nowThis early-stage study is testing the safety of a new type of personalized cell therapy for patients with multiple myeloma that has returned or stopped responding to other treatments and has spread to other tissues. Doctors will collect and modify a patient's own immune cells to …
Matched conditions: RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM)
Phase: PHASE1 • Sponsor: Beijing GoBroad Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New 'Living Drug' trial offers hope for Tough-to-Treat blood cancer
Disease control Recruiting nowThis study is testing whether a new type of personalized immune cell therapy, called arlo-cel, works better than standard treatments for adults with multiple myeloma that has returned or stopped responding to prior therapies, including lenalidomide. Researchers will compare how l…
Matched conditions: RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM)
Phase: PHASE3 • Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New Two-Pronged attack on tough blood cancer
Disease control Recruiting nowThis early-stage study is testing the safety of a new type of cell therapy for people with multiple myeloma that has come back or stopped responding to other treatments and has spread outside the bone marrow. Doctors will give patients a one-time infusion of specially engineered …
Matched conditions: RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM)
Phase: PHASE1 • Sponsor: Beijing GoBroad Hospital • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC